Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

Por Demyttenaere, Koen, Desaiah, Durisala, Petit, Claude, Croenlein, Jens, Brecht, Stephan
Publicado em 2009

Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine

Por Demyttenaere, Koen, Desaiah, Durisala, Raskin, Joel, Cairns, Victoria, Brecht, Stephan
Publicado em 2014

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

Por Ball, Susan G, Desaiah, Durisala, Zhang, Qi, Thase, Michael E, Perahia, David G S
Publicado em 2013

The Significance of Treating Somatic Symptoms on Functional Outcome Improvement in Patients With Major Depressive Disorder: A Post Hoc Analysis of 2 Trials

Por Wise, Thomas N., Meyers, Adam L., Desaiah, Durisala, Mallinckrodt, Craig H., Robinson, Michael J., Kajdasz, Daniel K.
Publicado em 2008

Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a...

Por Romera, Irene, Montejo, Ángel L, Caballero, Fernando, Caballero, Luis, Arbesú, José, Polavieja, Pepa, Desaiah, Durisala, Gilaberte, Inmaculada
Publicado em 2011

Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries

Por Altin, Murat, El-Shafei, Ahmed A, Yu, Maria, Desaiah, Durisala, Treuer, Tamas, Zavadenko, Nikolay, Gao, Hong Yun
Publicado em 2013

Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of...

Por Ball, Susan G., Desaiah, Durisala, Spann, Melissa E., Zhang, Qi, Russell, James M., Robinson, Michael J., Demyttenaere, Koen
Publicado em 2011

Duloxetine in Practice-Based Clinical Settings: Assessing Effects on the Emotional and Physical Symptoms of Depression in an Open-Label, Multicenter Study

Por Wohlreich, Madelaine M., Wiltse, Curtis G., Desaiah, Durisala, Ye, Wenyu, Robinson, Rebecca L., Kroenke, Kurt, Kornstein, Susan G., Greist, John H.
Publicado em 2007

Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer

Por Gueorguieva, Ivelina, Cleverly, Ann, Desaiah, Durisala, Azaro, Analia, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Miles, Colin, Lahn, Michael M, Mitchell, Malcolm I, Rodon, Jordi
Publicado no Drugs Context (2016)

A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer

Por COHN, ALLEN, LAHN, MICHAEL M., WILLIAMS, KRISTEN E., CLEVERLY, ANN L., PITOU, CELINE, KADAM, SUNIL K., FARMEN, MARK W., DESAIAH, DURISALA, RAJU, ROBERT, CONKLING, PAUL, RICHARDS, DONALD
Publicado em 2014

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

Por Herbertz, Stephan, Sawyer, J Scott, Stauber, Anja J, Gueorguieva, Ivelina, Driscoll, Kyla E, Estrem, Shawn T, Cleverly, Ann L, Desaiah, Durisala, Guba, Susan C, Benhadji, Karim A, Slapak, Christopher A, Lahn, Michael M
Publicado no Drug Des Devel Ther (2015)

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

Por Upadhyaya, Himanshu P., Desaiah, Durisala, Schuh, Kory J., Bymaster, Frank P., Kallman, Mary J., Clarke, David O., Durell, Todd M., Trzepacz, Paula T., Calligaro, David O., Nisenbaum, Eric S., Emmerson, Paul J., Schuh, Leslie M., Bickel, Warren K., Allen, Albert J.
Publicado em 2013

Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced canc...

Por Rodón, Jordi, Carducci, Michael, Sepulveda-Sánchez, Juan M., Azaro, Analía, Calvo, Emiliano, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Gueorguieva, Ivelina, Cleverly, Ann, Pillay, N. Sokalingum, Desaiah, Durisala, Estrem, Shawn T., Paz-Ares, Luis, Holdhoff, Matthias, Blakeley, Jaishri, Lahn, Michael M., Baselga, Jose
Publicado no Invest New Drugs (2014)

First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

Por Rodon, Jordi, Carducci, Michael A., Sepulveda-Sánchez, Juan M, Azaro, Analia, Calvo, Emiliano, Seoane, Joan, Braña, Irene, Sicart, Elisabet, Gueorguieva, Ivelina, Cleverly, Ann L., Pillay, N. Sokalingum, Desaiah, Durisala, Estrem, Shawn T., Paz-Ares, Luis, Holdhoff, Matthias, Blakeley, Jaishri, Lahn, Michael M., Baselga, Jose
Publicado no Clin Cancer Res (2014)

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

Por Brandes, Alba A., Carpentier, Antoine F., Kesari, Santosh, Sepulveda-Sanchez, Juan M., Wheeler, Helen R., Chinot, Olivier, Cher, Lawrence, Steinbach, Joachim P., Capper, David, Specenier, Pol, Rodon, Jordi, Cleverly, Ann, Smith, Claire, Gueorguieva, Ivelina, Miles, Colin, Guba, Susan C., Desaiah, Durisala, Lahn, Michael M., Wick, Wolfgang
Publicado no Neuro Oncol (2016)

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed...

Por Zinner, Ralph G., Obasaju, Coleman K., Spigel, David R., Weaver, Robert W., Beck, J. Thaddeus, Waterhouse, David M., Modiano, Manuel R., Hrinczenko, Borys, Nikolinakos, Petros G., Liu, Jingyi, Koustenis, Andrew G., Winfree, Katherine B., Melemed, Symantha A., Guba, Susan C., Ortuzar, Waldo I., Desaiah, Durisala, Treat, Joseph A., Govindan, Ramaswamy, Ross, Helen J.
Publicado no J Thorac Oncol (2015)